×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: covid | novavax | vaccine | booster | protein-based

Novavax Seeks Authorization for COVID Vaccine Booster

vial of Novavax COVID vaccine, hand with surgical glove holding syringe, mask
(Dreamstime)

Monday, 15 August 2022 03:20 PM EDT

Novavax Inc said on Monday it had filed for U.S. authorization for use of its COVID-19 vaccine as a booster dose in people who had either received its shots or a different vaccine.

The application to the U.S. Food and Drug Administration comes in the face of a slow rollout in the United States, where the Novavax vaccine was authorized in July, despite expectations that it would convince vaccine skeptics to get inoculated.

"It's important for people to have a choice as they evaluate how to stay protected against COVID-19," Chief Executive Officer Stanley Erck said in a statement, referring to the Novavax vaccine that uses a traditional technology.

It is a protein-based vaccine that uses purified pieces of the virus to spur an immune response, a technology that has been used to combat diseases including hepatitis B and influenza.

Over 9,700 doses of the vaccine have been administered in the United States so far, out of a total 606 million doses given overall. More than 67% of the U.S. population has received two doses of a COVID-19 vaccine, according to the latest federal data.

The company last week halved its full-year revenue forecast as it expects no significant sales of its COVID-19 shot this year in the United States in the face of a supply glut and soft demand.

Novavax's shares rose 2% to $42.31 before the opening bell. (

© 2022 Thomson/Reuters. All rights reserved.


Health-News
Novavax Inc said on Monday it had filed for U.S. authorization for use of its COVID-19 vaccine as a booster dose in people who had either received its shots or a different vaccine.The application to the U.S. Food and Drug Administration comes in the face of a slow rollout...
covid, novavax, vaccine, booster, protein-based
231
2022-20-15
Monday, 15 August 2022 03:20 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved